Early Changes in Hepatitis C Virus (HCV) Levels in Response to Peginterferon and Ribavirin Treatment in Patients with Chronic HCV Genotype 1 InfectionHOOFNAGLE, Jay H; WAHED, Abdus S; BROWN, Robert S et al.The Journal of infectious diseases. 2009, Vol 199, Num 8, pp 1112-1120, issn 0022-1899, 9 p.Article

Prospective Analysis of Depression During Peginterferon and Ribavirin Therapy of Chronic Hepatitis C: Results of the Virahep-C StudyEVON, Donna M; RAMCHARRAN, Darmendra; BELLE, Steven H et al.The American journal of gastroenterology. 2009, Vol 104, Num 12, pp 2949-2958, issn 0002-9270, 10 p.Article

Assessing the validity of self-reported medication adherence in hepatitis C treatmentSMITH, Scott R; WAHED, Abdus S; KELLEY, Stephanie S et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 7-8, pp 1116-1123, issn 1060-0280, 8 p.Article

Selective decrease in hepatitis C virus-specific immunity among african americans and outcome of antiviral therapyROSEN, Hugo R; WESTON, Scott J; IM, Kyungah et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 2, pp 350-358, issn 0270-9139, 9 p.Article

Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapyTAYLOR, Milton W; TSUKAHARA, Takuma; HOWELL, Charles et al.Journal of virology. 2007, Vol 81, Num 7, pp 3391-3401, issn 0022-538X, 11 p.Article

Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virusYEE, Leland J; TANG, Yong-Ming; FONTANA, Robert J et al.Hepatology (Baltimore, Md.). 2007, Vol 46, Num 1, pp 74-83, issn 0270-9139, 10 p.Article

Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapyDONLIN, Maureen J; CANNON, Nathan A; ERMEI YAO et al.Journal of virology. 2007, Vol 81, Num 15, pp 8211-8224, issn 0022-538X, 14 p.Article

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomesMENGSHOL, J. A; GOLDEN-MASON, L; CASTELBLANCO, N et al.Gut. 2009, Vol 58, Num 7, pp 964-973, issn 0017-5749, 10 p.Article

Race, insulin resistance and hepatic steatosis in chronic hepatitis CCONJEEVARAM, Hari S; KLEINER, David E; EVERHART, Jay E et al.Hepatology (Baltimore, Md.). 2007, Vol 45, Num 1, pp 80-87, issn 0270-9139, 8 p.Article

Natural Killer Inhibitory Receptor Expression Associated with Treatment Failure and Interleukin-28B Genotype in Patients with Chronic Hepatitis CGOLDEN-MASON, Lucy; BAMBHA, Kiran M; LINLING CHENG et al.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 5, pp 1559-1569, issn 0270-9139, 11 p.Article

Associations Between Serum Lipids and Hepatitis C Antiviral Treatment EfficacyRAMCHARRAN, Darmendra; WAHED, Abdus S; CONJEEVARAM, Hari S et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 3, pp 854-863, issn 0270-9139, 10 p.Article

Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infectionFONTANA, Robert J; KLEINER, David E; BILONICK, Richard et al.Hepatology (Baltimore, Md.). 2006, Vol 44, Num 4, pp 925-935, issn 0270-9139, 11 p.Article

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis CXIAOWEN SU; YEE, Leland J; LIANG, T. Jake et al.Journal of hepatology. 2008, Vol 49, Num 2, pp 184-191, issn 0168-8278, 8 p.Article

Prospective analysis of effector and regulatory CD4⁺ T cells in chronic HCV patients undergoing combination antiviral therapyBURTON, James R; KLARQUIST, Jared; IM, Kyungah et al.Journal of hepatology. 2008, Vol 49, Num 3, pp 329-338, issn 0168-8278, 10 p.Article